Prescott E, Angeras O, Erlinge D, Grove EL, et al. Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study. Int J Cardiol 2022 Jul 13. pii: S0167-5273(22)01084.
PMID: 35842004